1 June 2023 false No description of principal activity Taxfiler 2024.6 12003605business:PrivateLimitedCompanyLtd2023-06-012024-05-31 120036052023-05-31 120036052023-06-012024-05-31 12003605business:AuditExempt-NoAccountantsReport2023-06-012024-05-31 12003605business:FilletedAccounts2023-06-012024-05-31 120036052024-05-31 12003605business:Director12023-06-012024-05-31 12003605business:Director22023-06-012024-05-31 12003605business:RegisteredOffice2023-06-012024-05-31 120036052023-05-31 12003605core:WithinOneYear2024-05-31 12003605core:WithinOneYear2023-05-31 12003605core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-05-31 12003605core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-05-31 12003605core:PreviouslyStatedAmount2024-05-31 12003605core:PreviouslyStatedAmount2023-05-31 12003605business:SmallEntities2023-06-012024-05-31 12003605countries:EnglandWales2023-06-012024-05-31 12003605core:PlantMachinery2023-06-012024-05-31 12003605core:ComputerEquipment2023-05-31 12003605core:ComputerEquipment2023-06-012024-05-31 12003605core:ComputerEquipment2024-05-31 12003605business:Director122023-06-012024-05-31 12003605business:Director122023-05-31 12003605business:Director122024-05-31 12003605business:Director212023-06-012024-05-31 12003605business:Director212023-05-31 12003605business:Director212024-05-31 120036052022-06-012023-05-31 iso4217:GBP xbrli:pure
Company Registration No. 12003605 (England and Wales)
Anjin Preclinical Ltd Unaudited accounts for the year ended 31 May 2024
Anjin Preclinical Ltd Unaudited accounts Contents
Page
- 2 -
Anjin Preclinical Ltd Company Information for the year ended 31 May 2024
Directors
Elizabeth Anne Kelly Michael Douglas Kelly
Company Number
12003605 (England and Wales)
Registered Office
2 HIGH HOUSE COTTAGES PRESTON CROSS LEDBURY HR8 2LH UNITED KINGDOM
- 3 -
Anjin Preclinical Ltd Statement of financial position as at 31 May 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
5,989 
7,358 
Current assets
Debtors
7,043 
39,446 
Cash at bank and in hand
481,027 
752,426 
488,070 
791,872 
Creditors: amounts falling due within one year
100,475 
(119,796)
Net current assets
588,545 
672,076 
Net assets
594,534 
679,434 
Capital and reserves
Profit and loss account
594,534 
679,434 
Shareholders' funds
594,534 
679,434 
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 11 February 2024 and were signed on its behalf by
Michael Douglas Kelly Director Company Registration No. 12003605
- 4 -
Anjin Preclinical Ltd Notes to the Accounts for the year ended 31 May 2024
1
Statutory information
Anjin Preclinical Ltd is a private company, limited by shares, registered in England and Wales, registration number 12003605. The registered office is 2 HIGH HOUSE COTTAGES, PRESTON CROSS, LEDBURY, HR8 2LH, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% - Straight Line Method
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 June 2023
18,007 
Additions
2,313 
At 31 May 2024
20,320 
Depreciation
At 1 June 2023
10,649 
Charge for the year
3,682 
At 31 May 2024
14,331 
Net book value
At 31 May 2024
5,989 
At 31 May 2023
7,358 
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
7,043 
36,598 
Accrued income and prepayments
- 
2,848 
7,043 
39,446 
- 5 -
Anjin Preclinical Ltd Notes to the Accounts for the year ended 31 May 2024
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Taxes and social security
10,209 
64,129 
Other creditors
- 
5,035 
Loans from directors
(110,917)
20,432 
Accruals
233 
30,200 
(100,475)
119,796 
7
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Short Term Loan
- 
55,459 
- 
55,459 
Short Term Loan
- 
55,458 
- 
55,458 
- 
110,917 
- 
110,917 
Repaid 28/02/2025
8
Transactions with related parties
Loans to Directors (Note 7)
9
Average number of employees
During the year the average number of employees was 2 (2023: 2).
- 6 -